- Dr. Susanta Pahari is a Professor in The Department of Biochemistry, Skyline University, Nigeria.He has a PhD in Bioc... moreDr. Susanta Pahari is a Professor in The Department of Biochemistry, Skyline University, Nigeria.He has a PhD in Biochemistry, MSc in Biochemistry from University of Calcutta, India. In addition, he also has BSc in Chemistry from the University of Calcutta, India.ExperienceHe has over 20 years’ of experience in teaching, training, research and administration in India as well as in abroad. He has done his research work in Indian premier institutes as well as in Singapore, Sweden (Stockholm) and Taipei. He has taught in Jain University, CMR University and leading colleges under Bangalore University, India. He has also worked as Director of Redit
ABSTRACT
Many snake venoms contain toxins which produce profound cardiovascular effects. The site of action of these toxins includes cardiac muscle, vascular smooth muscle and the capillary vascular bed. Some snake venoms, for example, contain... more
Many snake venoms contain toxins which produce profound cardiovascular effects. The site of action of these toxins includes cardiac muscle, vascular smooth muscle and the capillary vascular bed. Some snake venoms, for example, contain peptides that inhibit angiotensin converting enzyme and potentiate the biological actions of bradykinin. Other snake venoms contain structural and functional equivalents of mammalian natriuretic peptides. Sarafotoxins are short peptide toxins found in the venoms of snakes from Atractaspis spp. which display potent vasoconstriction properties. These peptides, which share a high degree of sequence identity with endothelins, recognize and bind to endothelin receptors. Snakes have also evolved toxins which block L-type Ca(2+) currents (eg. calciseptine, FS2 toxins, C(10)S(2)C(2) and S(4)C(8)). Snake venom proteins have also been shown to increase vascular permeability. One such protein, increasing capillary permeability protein (ICPP) has recently been isolated from the venom of Vipera lebetina. ICPP is an extremely potent permeability factor with a structure similar to vascular endothelial growth factor (VEGF). Thus there is a vast array of snake toxins with potent cardiovascular activity. Some of these proteins and peptides have proven to be highly selective tools in the study of physiological processes. Others have been used as probes of potential therapeutic targets or as lead compounds in the development of therapeutic agents. Therefore these and other related snake venom proteins hold great promise in the future understanding and treatment of cardiovascular diseases.
Research Interests:
Research Interests: Evolutionary Biology, Genetics, Biology, Medicine, Phylogeny, and 15 moreSequence alignment, Animals, Gene Order, Evolutionary History, Gene Duplication, Gene Structure, Introns, Exon Evolution, Biological activity, Amino Acid Sequence, Sistrurus Venom, Rattlesnake Venom, Gene Evolution, Gene Family, and Molecular Sequence Data
Research Interests:
Research Interests: Evolutionary Biology, Snake venoms, Phylogeny, Enzymes, Sequence alignment, and 15 moreAnimals, Peptides, Gene Duplication, ribosomal RNA, Snake Venom, Crotalus, Mechanism of action, Amino Acid Sequence, Base Sequence, cDNA library, Biochemistry and cell biology, Gene Expression Regulation, Gene expression profiling, Molecular Sequence Data, and Medical biochemistry and metabolomics
Dendritic cells (DCs) and macrophages (Mφs) are professional antigen-presenting cells (APCs) that can efficiently phagocytose Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB). It is quite interesting to mention... more
Dendritic cells (DCs) and macrophages (Mφs) are professional antigen-presenting cells (APCs) that can efficiently phagocytose Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB). It is quite interesting to mention here that DCs and Mφs use distinct strategies to combat and eliminate Mtb. Similarly, Mtb employs different mechanisms to counteract the action of DCs and Mφs. Mφs are evolved with specialized, innate, defensive machinery to restrict growth of Mtb at the initial phase of infection. However, DCs are more endowed toward initiating adaptive immunity by activating naïve T cells. During encounter with Mtb, DCs and Mφs deliver discrete functions via triggering through different pattern recognition receptors (PRRs) expressed by these APCs. Mtb-infected DCs and Mφs show differential expression of genes encoding cytokines, chemokines, costimulatory molecules, and adhesion molecules. Interestingly, Mtb impairs the immune defensive machinery by exploiting var...
Research Interests:
Many snake venoms contain toxins which produce profound cardiovascular effects. The site of action of these toxins includes cardiac muscle, vascular smooth muscle and the capillary vascular bed. Some snake venoms, for example, contain... more
Many snake venoms contain toxins which produce profound cardiovascular effects. The site of action of these toxins includes cardiac muscle, vascular smooth muscle and the capillary vascular bed. Some snake venoms, for example, contain peptides that inhibit angiotensin converting enzyme and potentiate the biological actions of bradykinin. Other snake venoms contain structural and functional equivalents of mammalian natriuretic peptides. Sarafotoxins are short peptide toxins found in the venoms of snakes from Atractaspis spp. which display potent vasoconstriction properties. These peptides, which share a high degree of sequence identity with endothelins, recognize and bind to endothelin receptors. Snakes have also evolved toxins which block L-type Ca(2+) currents (eg. calciseptine, FS2 toxins, C(10)S(2)C(2) and S(4)C(8)). Snake venom proteins have also been shown to increase vascular permeability. One such protein, increasing capillary permeability protein (ICPP) has recently been isolated from the venom of Vipera lebetina. ICPP is an extremely potent permeability factor with a structure similar to vascular endothelial growth factor (VEGF). Thus there is a vast array of snake toxins with potent cardiovascular activity. Some of these proteins and peptides have proven to be highly selective tools in the study of physiological processes. Others have been used as probes of potential therapeutic targets or as lead compounds in the development of therapeutic agents. Therefore these and other related snake venom proteins hold great promise in the future understanding and treatment of cardiovascular diseases.